1. Home
  2. CACC vs CYTK Comparison

CACC vs CYTK Comparison

Compare CACC & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CACC
  • CYTK
  • Stock Information
  • Founded
  • CACC 1972
  • CYTK 1997
  • Country
  • CACC United States
  • CYTK United States
  • Employees
  • CACC 2431
  • CYTK N/A
  • Industry
  • CACC Finance: Consumer Services
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • CACC Finance
  • CYTK Health Care
  • Exchange
  • CACC Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • CACC 4.6B
  • CYTK 4.6B
  • IPO Year
  • CACC 1992
  • CYTK 2004
  • Fundamental
  • Price
  • CACC $425.73
  • CYTK $66.44
  • Analyst Decision
  • CACC Sell
  • CYTK Strong Buy
  • Analyst Count
  • CACC 2
  • CYTK 15
  • Target Price
  • CACC $465.00
  • CYTK $77.87
  • AVG Volume (30 Days)
  • CACC 180.5K
  • CYTK 1.9M
  • Earning Date
  • CACC 10-30-2025
  • CYTK 11-05-2025
  • Dividend Yield
  • CACC N/A
  • CYTK N/A
  • EPS Growth
  • CACC 151.44
  • CYTK N/A
  • EPS
  • CACC 37.89
  • CYTK N/A
  • Revenue
  • CACC $1,232,900,000.00
  • CYTK $87,211,000.00
  • Revenue This Year
  • CACC $156.09
  • CYTK $363.61
  • Revenue Next Year
  • CACC $2.31
  • CYTK $64.33
  • P/E Ratio
  • CACC $11.11
  • CYTK N/A
  • Revenue Growth
  • CACC 45.72
  • CYTK 2609.26
  • 52 Week Low
  • CACC $401.90
  • CYTK $29.31
  • 52 Week High
  • CACC $560.00
  • CYTK $67.98
  • Technical
  • Relative Strength Index (RSI)
  • CACC 38.18
  • CYTK 66.23
  • Support Level
  • CACC $401.90
  • CYTK $64.11
  • Resistance Level
  • CACC $452.31
  • CYTK $67.98
  • Average True Range (ATR)
  • CACC 22.94
  • CYTK 2.68
  • MACD
  • CACC -1.55
  • CYTK 0.31
  • Stochastic Oscillator
  • CACC 26.97
  • CYTK 85.90

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: